Director, Dr. Shailaja Kale’s Diabetes & Speciality Clinics; Director, Orange Diabetes Foundation; Associate Professor, KEM Hospital, Pune

This session focuses on the evolving role of alpha-glucosidase inhibitors (AGIs) in managing diabetes in Indian patients, where postprandial hyperglycemia and dietary patterns present unique challenges. It highlights patient-centric approaches, clinical evidence, and practical strategies for integrating AGIs into routine care. A relevant discussion on tailoring diabetes management to achieve effective and culturally appropriate outcomes.

Dr. Shailaja Kale

-

-

-

-

Upcoming Sessions